Biogen Acquires License to Mitsubishi Tanabe Pharma’s Compound for Autoimmune Disorders, IBD
News
One of the oldest independent biotechnology companies, focused on discovering and developing worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders, Biogen Idec, has just announced ... Read more